Advertisement

Pharmacotherapy of pain

  • Michael Serpell

Abstract

In order to prescribe for and treat painful conditions pharmacologically it is important to know whether the pain to be treated is nociceptive, neuropathic or mixed in nature. Neuropathic pain in particular may not respond to conventional analgesics. A simple and successful way to use analgesics in most pain conditions requires application of the World Health Organization (WHO) pain ladder [1] and use of multimodal analgesia. This chapter will focus on non-opioid, opioid and anti-neuropathic analgesic medications in current usage and will comment on their efficacy and safe prescription.

Keywords

Neuropathic Pain Cancer Pain NMDA Antagonist Strong Opioid Neuropathic Pain Condition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    World Health Organization. Cancer Pain Relief and Palliative Care (Technical Report Series 804). Geneva: WHO, 1990: 1–75.Google Scholar
  2. 2.
    Moore A, Edwards J, Barden J, McQuay H. Bandolier’s Little Book of Pain. Oxford: Oxford University Press, 2003.Google Scholar
  3. 3.
    Nikles CJ, Yelland M, Del Mar C, Wilkinson D. The role of paracetamol in chronic pain: an evidence-based approach. Am J Ther 2005; 12:80–91.PubMedCrossRefGoogle Scholar
  4. 4.
    Schug SA, Manopas A. Update on the role of non-opioids for postoperative pain treatment. Best Pract Res Clin Anaesthesiol 2007; 21:15–30.PubMedCrossRefGoogle Scholar
  5. 5.
    Hyllested M, Jones S, Pedersen JL, Kehlet H. Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review. Br J Anaesth 2002; 88:199–214.PubMedCrossRefGoogle Scholar
  6. 6.
    Moore PK, Marshall M. Nitric oxide releasing acetaminophen (nitroacetaminophen). Dig Liver Dis 2003; 35:S49–60.CrossRefGoogle Scholar
  7. 7.
    Gaita’n G, Ahuir FJ, Herrero JF. Enhancement of fentanyl antinociception by subeffective doses of nitroparacetamol (NCX-701) in acute nociception and in carrageenan-induced monoarthritis. Life Sci 2005; 77:85–95.PubMedCrossRefGoogle Scholar
  8. 8.
    Aronson JK (ed.). Phenazone. In: Meyler’s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Oxford: Elsevier, 2006: 2794.Google Scholar
  9. 9.
    Buvanendran A, Reuben SS, Kroin JS. Recent advances in nonopioid analgesics for acute pain management. Tech Reg Anaesth Pain Manag 2007; 11:19–26.CrossRefGoogle Scholar
  10. 10.
    Langford RM, Mehta V. Selective cyclo-oxygenase inhibition: its role in pain and anaesthesia. Biomed Pharmacother 2006; 60:323–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Moskowitz RW, Abramson SB, Berenbaum F, et al. Coxibs and NSAIDs — is the air any clearer? Osteoarthritis Cartilage 2007; 15:849–56.PubMedCrossRefGoogle Scholar
  12. 12.
    Lyseng-Williamson KA, Curran MP. Lumiracoxib. Drugs 2004; 64:2237–46.PubMedCrossRefGoogle Scholar
  13. 13.
    Watkins L, Hutchison MR, Ledeboer A, et al. Glia as the ‘bad guys’: Implications for improving pain control and the clinical utility of opioids. Brain, Behav Immun 2007; 21:131–46.CrossRefGoogle Scholar
  14. 14.
    APA: Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.Google Scholar
  15. 15.
    Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007; 129:235–55.PubMedCrossRefGoogle Scholar
  16. 16.
    McNicol E. Opioid Side-Effects. Pain: Clinical Updates, Volume XV; Issue 2. Seattle, WA: International Association for the Study of Pain 2007 (available online from http://www.iasp-pain.org).Google Scholar
  17. 17.
    Koppert W. Opioid induced hyperalgesia — pathophysiology and clinical relevance. Acute Pain 2007; 9:21–34.CrossRefGoogle Scholar
  18. 18.
    Sasada M, Smith S. Drugs in Anaesthesia and Intensive Care, 3rd edn. Oxford: Oxford University Press, 2003.Google Scholar
  19. 19.
    Grass J. Patient controlled analgesia. Anesth Analg 2005; 101:S44–61.CrossRefGoogle Scholar
  20. 20.
    Owen H, Plummer JL, Armstrong I, et al. Variables of patient controlled analgesia 1: Bolus size. Anaesthesia 1989; 44:7–10.PubMedCrossRefGoogle Scholar
  21. 21.
    MacIntyre P. Safety and efficacy of patient controlled analgesia. Br J Anaesth 2001; 87:36–46.PubMedCrossRefGoogle Scholar
  22. 22.
    Hudcova J, McNicol E, Quah C, Lau J, et al. Patient controlled opioid analgesia versus conventional analgesia for postoperative pain. Cochrane Database of Systematic Reviews 2006 (4): CD003348.Google Scholar
  23. 23.
    Lehmann K. Recent developments in patient controlled analgesia. J Pain Symptom Manage 2005; 29:S72–89.CrossRefGoogle Scholar
  24. 24.
    Dahan A. Opioid induced respiratory failure: new data on buprenorphine. Pall Med 2006; 20:3–8.CrossRefGoogle Scholar
  25. 25.
    Farr SJ, Otulana BA. Pulmonary delivery of opioids as pain therapeutics. Adv Drug Deliv Rev 2006; 58:1076–88.PubMedCrossRefGoogle Scholar
  26. 26.
    Langford RM, Rawal N. A new needle free PCA system. The fentanyl iontophoretic transdermal system. Acute Pain 2006; 8:151–3.CrossRefGoogle Scholar
  27. 27.
    Minkowitz HS. The fentanyl iontophoretic transdermal system: a review. Tech Reg Anesth Pain Manage 2007; 11:3–8.CrossRefGoogle Scholar
  28. 28.
    Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: a systematic review of efficacy and safety. Pain 2004; 112:372–80.PubMedCrossRefGoogle Scholar
  29. 29.
    Mercadante S, Bruera E. Opioid switching: A systematic and critical review. Cancer Treat Rev 2006; 32:304–15.PubMedCrossRefGoogle Scholar
  30. 30.
    McIntyre P, Ready BL. Acute Pain Management: A Practical Guide, 2nd edn. Oxford: Elsevier, 2002.Google Scholar
  31. 31.
    Recommendations for the Appropriate Use of Opioids for Persistent Non-Cancer Pain. London: British Pain Society, 2004 (available from http://www.britishpainsociety.org/opioid_doc_2004.pdf). Last accessed 27 January 2008.Google Scholar
  32. 32.
    Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83:389–400.PubMedCrossRefGoogle Scholar
  33. 33.
    Attal N, Cruccu G, Haanpaa M, et al. EFN S guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13:1153–69.PubMedCrossRefGoogle Scholar
  34. 34.
    Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews 2005 (3): CD005454.Google Scholar
  35. 35.
    Bousher D. The effects of pre-emptive treatment of post-herpetic neuralgia with amitriptyline: a randomised, double-blind, placebo controlled trial. J Pain Symptom Manage 1997; 13:327–31.CrossRefGoogle Scholar
  36. 36.
    Kalso E, Tasmuth T, Neuvonen PJ. Amitriptyline effectively reduces neuropathic pain following treatment of breast cancer. Pain 1996; 6:17–24.Google Scholar
  37. 37.
    Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005; 118:289–305.PubMedCrossRefGoogle Scholar
  38. 38.
    Wernicke JF, Pritchett YL, D’Souza DN, et al. A randomised controlled trial of duloxetine in diabetic peripheral neuropathy. Neurology 2006; 67:1411–20.PubMedCrossRefGoogle Scholar
  39. 39.
    Wiffen P, Collins S, McQuay H, et al. Anticonvulsant drugs for acute and chronic pain (review). Cochrane Database of Systematic Reviews 2005 (3); CD001133.Google Scholar
  40. 40.
    Seib RK, Paul JE. Pre-operative gabapentin for postoperative analgesia: A meta-analysis. Can J Anaesth 2006; 53:461–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Hurley RW, Cohen SP, Williams KA, et al. The analgesic effects of perioperative gabapentin on postoperative pain: A meta-analysis. Reg Anesth Pain Med 2006; 31:237–47.PubMedGoogle Scholar
  42. 42.
    Challapalli V, Tremont-Lukats IW, McNicol ED, Carr DB. Systemic administration of local anaesthetic agents to relieve neuropathic pain. Cochrane Database of Systematic Reviews 2005 (4): CD003345.Google Scholar
  43. 43.
    Galer BS, Jensen MP, Ma T, et al. The lidocaine patch 5% effectively treats all neuropathic qualities: results of a randomised, double-blind, vehicle controlled, 3 week efficacy study with the use of the neuropathic pain scale. Clin J Pain 2002; 5:297–301.CrossRefGoogle Scholar
  44. 44.
    Katz J, McCartney CL. Current status of pre-emptive analgesia. Curr Opin Anaesth 2002; 15:435–41.CrossRefGoogle Scholar
  45. 45.
    Bell RF, Dahl JB, Moore RA, Kalso E. Perioperative ketamine for acute neuropathic pain. Cochrane Database of Systematic Reviews 2006 (1): CD004603.Google Scholar
  46. 46.
    Hocking G, Visser EJ, Schug S, Cousins MJ. Ketamine: Does life begin at forty? Pain: Clinical Updates (Volume XV; Issue 3. Seattle, WA: International Association for the Study of Pain 2007 (available online from http://www.iasp-pain.org).Google Scholar
  47. 47.
    Auburn F, Marmion F. The elderly patient and postoperative pain treatment. Best Pract Res Clin Anaesthesiol 2007; 21:109–27.CrossRefGoogle Scholar

Copyright information

© Current Medicine Group, a part of Springer Science+Business Media 2008

Authors and Affiliations

  • Michael Serpell
    • 1
  1. 1.University Department of AnaesthesiaGartnavel General HospitalGlasgowScotland

Personalised recommendations